Citadel Advisors
COLL icon

Citadel Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.1M Sell
240,156
-269,999
-53% -$7.98M ﹤0.01% 1612
2025
Q1
$15.2M Buy
510,155
+157,184
+45% +$4.69M ﹤0.01% 1027
2024
Q4
$10.1M Buy
352,971
+221,627
+169% +$6.35M ﹤0.01% 1317
2024
Q3
$5.08M Sell
131,344
-41,326
-24% -$1.6M ﹤0.01% 1749
2024
Q2
$5.56M Buy
172,670
+59,927
+53% +$1.93M ﹤0.01% 1606
2024
Q1
$4.38M Buy
112,743
+2,235
+2% +$86.8K ﹤0.01% 1853
2023
Q4
$3.4M Buy
+110,508
New +$3.4M ﹤0.01% 1960
2023
Q3
Sell
-76,543
Closed -$1.64M 5941
2023
Q2
$1.64M Sell
76,543
-109,820
-59% -$2.36M ﹤0.01% 2577
2023
Q1
$4.47M Buy
186,363
+64,241
+53% +$1.54M ﹤0.01% 1905
2022
Q4
$2.83M Buy
122,122
+12,733
+12% +$295K ﹤0.01% 2273
2022
Q3
$1.75M Sell
109,389
-54,918
-33% -$880K ﹤0.01% 2861
2022
Q2
$2.91M Buy
164,307
+57,782
+54% +$1.02M ﹤0.01% 2380
2022
Q1
$2.17M Buy
+106,525
New +$2.17M ﹤0.01% 2920
2021
Q4
Sell
-23,933
Closed -$473K 6532
2021
Q3
$473K Buy
23,933
+3,261
+16% +$64.4K ﹤0.01% 4592
2021
Q2
$489K Sell
20,672
-29,685
-59% -$702K ﹤0.01% 4732
2021
Q1
$1.19M Sell
50,357
-63,309
-56% -$1.5M ﹤0.01% 3729
2020
Q4
$2.28M Buy
113,666
+38,924
+52% +$780K ﹤0.01% 2443
2020
Q3
$1.56M Buy
74,742
+53,096
+245% +$1.11M ﹤0.01% 2515
2020
Q2
$379K Sell
21,646
-125,519
-85% -$2.2M ﹤0.01% 3639
2020
Q1
$2.4M Buy
+147,165
New +$2.4M ﹤0.01% 2061
2019
Q4
Sell
-10,873
Closed -$125K 4671
2019
Q3
$125K Sell
10,873
-23,230
-68% -$267K ﹤0.01% 4220
2019
Q2
$448K Sell
34,103
-124,884
-79% -$1.64M ﹤0.01% 3618
2019
Q1
$2.41M Buy
158,987
+49,668
+45% +$752K ﹤0.01% 2157
2018
Q4
$1.88M Sell
109,319
-81,437
-43% -$1.4M ﹤0.01% 2267
2018
Q3
$2.81M Buy
190,756
+170,197
+828% +$2.51M ﹤0.01% 1952
2018
Q2
$490K Sell
20,559
-318,250
-94% -$7.59M ﹤0.01% 3144
2018
Q1
$8.66M Sell
338,809
-521,918
-61% -$13.3M ﹤0.01% 1012
2017
Q4
$15.9M Buy
860,727
+316,694
+58% +$5.85M 0.01% 764
2017
Q3
$5.71M Buy
544,033
+493,671
+980% +$5.18M ﹤0.01% 1195
2017
Q2
$630K Sell
50,362
-19,547
-28% -$245K ﹤0.01% 2459
2017
Q1
$703K Buy
+69,909
New +$703K ﹤0.01% 2363